Tiazac

Tiazac is a brand name of diltiazem, approved by the FDA in the following formulation(s):

TIAZAC (diltiazem hydrochloride - capsule, extended release; oral)

• 
  Manufacturer: VALEANT INTL
  
  Approval date: September 11, 1995
  
  Strength(s): 120MG ^[AB4], 180MG ^[AB4], 240MG ^[AB4], 300MG ^[AB4], 360MG ^[AB4]


• 
  Manufacturer: VALEANT INTL
  
  Approval date: October 16, 1998
  
  Strength(s): 420MG ^[RLD][AB4]

Has a generic version of Tiazac been approved?

A generic version of Tiazac has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Tiazac and have been approved by the FDA:

diltiazem hydrochloride capsule, extended release; oral

• 
  Manufacturer: NESHER PHARMS
  
  Approval date: September 12, 2006
  
  Strength(s): 120MG ^[AB4], 180MG ^[AB4], 240MG ^[AB4], 300MG ^[AB4], 360MG ^[AB4], 420MG ^[AB4]


• 
  Manufacturer: SUN PHARMA GLOBAL
  
  Approval date: November 15, 2010
  
  Strength(s): 120MG ^[AB4], 180MG ^[AB4], 240MG ^[AB4], 300MG ^[AB4], 360MG ^[AB4]

DILTZAC (diltiazem hydrochloride capsule, extended release; oral)

• 
  Manufacturer: APOTEX INC
  
  Approval date: February 1, 2006
  
  Strength(s): 120MG ^[AB4], 180MG ^[AB4], 240MG ^[AB4], 300MG ^[AB4], 360MG ^[AB4]

TAZTIA XT (diltiazem hydrochloride capsule, extended release; oral)

• 
  Manufacturer: WATSON LABS FLORIDA
  
  Approval date: April 10, 2003
  
  Strength(s): 120MG ^[AB4], 180MG ^[AB4], 240MG ^[AB4], 300MG ^[AB4], 360MG ^[AB4]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Tiazac. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Extended release form of diltiazem
  Patent 5,529,791
  Issued: June 25, 1996
  Inventor(s): Deboeck; Arthur M. & Baudier; Philippe R.
  Assignee(s): Galephar P.R., Inc., Ltd.
  An extended-release galenical form of Diltiazem or a pharmaceutically acceptable salt thereof, which comprises beads containing said Diltiazem or a pharmaceutically acceptable salt thereof as an active ingredient and a wetting agent, said beads being coated with a microporous membrane comprising at least a water-soluble or water-dispersible polymer or copolymer and a pharmaceutically acceptable adjuvant.
  
  Patent expiration dates:
  
  
  • June 25, 2013
    
  
  

See also...

• Tiazac Consumer Information (Drugs.com)
• Tiazac 24-Hour Extended-Release Beads Capsules Consumer Information (Wolters Kluwer)
• Tiazac Consumer Information (Cerner Multum)
• Tiazac Advanced Consumer Information (Micromedex)
• Diltiazem Consumer Information (Drugs.com)
• Diltiazem Consumer Information (Wolters Kluwer)
• Diltiazem 12-Hour Sustained-Release Capsules Consumer Information (Wolters Kluwer)
• Diltiazem 24-Hour Extended-Release Beads Capsules Consumer Information (Wolters Kluwer)
• Diltiazem 24-Hour Extended-Release Beads Tablets Consumer Information (Wolters Kluwer)
• Diltiazem 24-Hour Sustained-Release Beads Capsules Consumer Information (Wolters Kluwer)
• Diltiazem 24-Hour Sustained-Release Capsules Consumer Information (Wolters Kluwer)
• Diltiazem Immediate-Release Tablets Consumer Information (Wolters Kluwer)
• Dilt-CD Consumer Information (Cerner Multum)
• Diltiazem Consumer Information (Cerner Multum)
• Dilt-CD Advanced Consumer Information (Micromedex)
• Diltiazem Advanced Consumer Information (Micromedex)
• Diltiazem Intravenous Advanced Consumer Information (Micromedex)
• Diltiazem Hydrochloride AHFS DI Monographs (ASHP)